Biotechnology Companies By Operating Margin

Operating Margin
Operating MarginEfficiencyMarket RiskExp Return
1BNOX Bionomics Ltd ADR
89.1
 0.01 
 22.94 
 0.33 
2QTTB Q32 Bio
5.18
(0.10)
 4.78 
(0.46)
3HALO Halozyme Therapeutics
0.56
(0.11)
 3.69 
(0.42)
4UTHR United Therapeutics
0.55
 0.05 
 1.72 
 0.09 
5ADAP Adaptimmune Therapeutics Plc
0.54
(0.17)
 4.73 
(0.83)
6GNFT Genfit
0.51
 0.02 
 4.60 
 0.09 
7MGNX MacroGenics
0.49
 0.00 
 4.24 
(0.01)
8XOMAP XOMA Corp
0.47
 0.07 
 0.77 
 0.05 
9XOMAO XOMA Corporation
0.47
 0.12 
 0.41 
 0.05 
10ALVO Alvotech
0.46
 0.05 
 1.63 
 0.08 
11ALVOW Alvotech Warrant
0.46
 0.13 
 141.08 
 18.12 
12GILD Gilead Sciences
0.42
 0.18 
 1.42 
 0.25 
13KRYS Krystal Biotech
0.42
(0.07)
 2.42 
(0.16)
14VRTX Vertex Pharmaceuticals
0.41
(0.05)
 1.73 
(0.09)
15MEIP MEI Pharma
0.4
(0.06)
 2.62 
(0.15)
16CPRX Catalyst Pharmaceuticals
0.4
 0.04 
 1.87 
 0.08 
17GMAB Genmab AS
0.38
(0.30)
 1.48 
(0.44)
18EXEL Exelixis
0.35
 0.20 
 2.36 
 0.48 
19REGN Regeneron Pharmaceuticals
0.33
(0.43)
 1.70 
(0.73)
20ADMA ADMA Biologics
0.33
 0.07 
 4.76 
 0.34 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations. A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.